|1.||Webb, E F: 1 article (02/2000)|
|2.||Reddy, M: 1 article (02/2000)|
|3.||Truneh, A: 1 article (02/2000)|
|4.||Podolin, P L: 1 article (02/2000)|
|5.||Griswold, D E: 1 article (02/2000)|
|1.||Contact Dermatitis (Eczema, Contact)
02/01/2000 - "Administration of a single 2-mg dose of either clenoliximab or keliximab to HuCD4/Tg mice prior to sensitization significantly reduced post-challenge tissue swelling, and levels of IFN-gamma and IL-4, indicating that CD4+ T-cell depletion is not required for anti-CD4 mAb-mediated inhibition of contact sensitivity. "
|1.||Interleukin-4 (Interleukin 4)